Cancer-related and treatment-related fatigue

Gynecologic Oncology

Volumn 136, Issue 3, 2015, Pages 446-452

  Wang, Xin Shelley ^a   Woodruff, Jeanie F ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Brief; Cancer related fatigue; Fatigue; Gynecological cancer; Inventory; Patient reported outcomes

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL MARKER; PSYCHOSTIMULANT AGENT; ANTINEOPLASTIC AGENT;

ALTERNATIVE MEDICINE; ANXIETY; CANCER RELATED FATIGUE; CAREGIVER; CLINICAL FEATURE; COGNITIVE THERAPY; DISEASE SEVERITY; FATIGUE; GOOD CLINICAL PRACTICE; GYNECOLOGIC CANCER; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PATIENT EDUCATION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PSYCHOTHERAPY; REVIEW; STRESS; ADVERSE EFFECTS; COMPLICATION; FEMALE; GENITAL NEOPLASMS, FEMALE; HEALTH STATUS INDICATOR; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; QUALITY OF LIFE; RADIOTHERAPY; SELF REPORT;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FATIGUE; FEMALE; GENITAL NEOPLASMS, FEMALE; HEALTH STATUS INDICATORS; HUMANS; PATIENT OUTCOME ASSESSMENT; QUALITY OF LIFE; RADIOTHERAPY; SELF REPORT;

EID: 84924268083     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2014.10.013     Document Type: Review

References (70)

1. T.R. Mendoza, X.S. Wang, C.S. Cleeland, M. Morrissey, B.A. Johnson, and J.K. Wendt The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory Cancer 85 1999 1186 1196
2. P. Servaes, M.F. Gielissen, S. Verhagen, and G. Bleijenberg The course of severe fatigue in disease-free breast cancer patients: a longitudinal study Psychooncology 16 2007 787 795
3. X.S. Wang, F. Zhao, M.J. Fisch, A.M. O'Mara, D. Cella, and T.R. Mendoza Prevalence and characteristics of moderate to severe fatigue: a multicenter study in cancer patients and survivors Cancer 120 2014 425 432
4. R.D. Alvarez, M.W. Sill, S.A. Davidson, C.Y. Muller, D.P. Bender, and R.L. DeBernardo A phase II trial of intraperitoneal EGEN-001, an IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer: a gynecologic oncology group study Gynecol Oncol 133 2014 433 438
5. L.P. Martin, M. Sill, M.S. Shahin, M. Powell, P. DiSilvestro, and L.M. Landrum A phase II evaluation of AMG 102 (rilotumumab) in the treatment of persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: a Gynecologic Oncology Group study Gynecol Oncol 132 2014 526 530
6. N.J. Anderson, and E.D. Hacker Fatigue in women receiving intraperitoneal chemotherapy for ovarian cancer: a review of contributing factors Clin J Oncol Nurs 12 2008 445 454
7. L.A. Williams, S. Agarwal, D.C. Bodurka, A.K. Saleeba, C.C. Sun, and C.S. Cleeland Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer J Pain Symptom Manage 46 2013 837 845
8. M.H. Sailors, D.C. Bodurka, I. Gning, L.M. Ramondetta, L.A. Williams, and T.R. Mendoza Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer Gynecol Oncol 130 2013 323 328
9. A.M. Barsevick, C.S. Cleeland, D.C. Manning, A.M. O'Mara, B.B. Reeve, and J.A. Scott ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials J Pain Symptom Manage 39 2010 1086 1099
10. V. Mock, A. Atkinson, A.M. Barsevick, A.M. Berger, B. Cimprich, and M.A. Eisenberger Cancer-related fatigue. Clinical practice guidelines in oncology J Natl Compr Canc Netw 5 2007 1054 1078
11. X.S. Wang Pathophysiology of cancer-related fatigue Clin J Oncol Nurs 12 2008 11 20
12. C.W. Given, B. Given, F. Azzouz, S. Kozachik, and M. Stommel Predictors of pain and fatigue in the year following diagnosis among elderly cancer patients J Pain Symptom Manage 21 2001 456 466
13. K.B. Peters, M.J. West, W.E. Hornsby, E. Waner, A.D. Coan, and F. McSherry Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients J Neurooncol 2014 [Epub 2014 Aug 13]
14. X.S. Wang, D.L. Fairclough, Z. Liao, R. Komaki, J.Y. Chang, and G.M. Mobley Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptoms J Clin Oncol 24 2006 4485 4491
15. O. Minton, F. Strasser, L. Radbruch, and P. Stone Identification of factors associated with fatigue in advanced cancer: a subset analysis of the European palliative care research collaborative computerized symptom assessment data set J Pain Symptom Manage 43 2012 226 235
16. G.J. Rubin, and M. Hotopf Systematic review and meta-analysis of interventions for postoperative fatigue Br J Surg 89 2002 971 984
17. Q. Shi, T.G. Smith, J.D. Michonski, K.D. Stein, C. Kaw, and C.S. Cleeland Symptom burden in cancer survivors 1 year after diagnosis: a report from the American Cancer Society's Studies of cancer survivors Cancer 117 2011 2779 2790
18. N. Téllez, J. Alonso, J. Rio, M. Tintoré, C. Nos, and X. Montalban The basal ganglia: a substrate for fatigue in multiple sclerosis Neuroradiology 50 2008 17 23
19. C.S. Cleeland, G.J. Bennett, R. Dantzer, P.M. Dougherty, A.J. Dunn, and C.A. Meyers Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? Cancer 97 2003 2919 2925
20. X.S. Wang, Q. Shi, L.A. Williams, C.S. Cleeland, G.M. Mobley, and J.M. Reuben Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation Cancer 113 2008 2102 2109
21. P.B. Fitzgerald, A.R. Laird, J. Maller, and Z.J. Daskalakis A meta-analytic study of changes in brain activation in depression Hum Brain Mapp 29 2008 683 695
22. M.A. Sprangers, M.S. Thong, M. Bartels, A. Barsevick, J. Ordonana, and Q. Shi Biological pathways, candidate genes, and molecular markers associated with quality-of-life domains: an update Qual Life Res 23 2014 1997 2013
23. T. Whistler, R. Taylor, R.C. Craddock, G. Broderick, N. Klimas, and E.R. Unger Gene expression correlates of unexplained fatigue Pharmacogenomics 7 2006 395 405
24. J.E. Bower, P.A. Ganz, M.R. Irwin, J.M. Arevalo, and S.W. Cole Fatigue and gene expression in human leukocytes: increased NF-kappaB and decreased glucocorticoid signaling in breast cancer survivors with persistent fatigue Brain Behav Immun 25 2011 147 150
25. A. Collado-Hidalgo, J.E. Bower, P.A. Ganz, S.W. Cole, and M.R. Irwin Inflammatory biomarkers for persistent fatigue in breast cancer survivors Clin Cancer Res 12 2006 2759 2766
26. C. Schubert, S. Hong, L. Natarajan, P.J. Mills, and J.E. Dimsdale The association between fatigue and inflammatory marker levels in cancer patients: a quantitative review Brain Behav Immun 21 2007 413 427
27. J.E. Bower, P.A. Ganz, M.R. Irwin, L. Kwan, E.C. Breen, and S.W. Cole Inflammation and behavioral symptoms after breast cancer treatment: do fatigue, depression, and sleep disturbance share a common underlying mechanism? J Clin Oncol 29 2011 3517 3522
28. X.S. Wang, L.A. Williams, S. Krishnan, Z. Liao, P. Liu, and L. Mao Serum sTNF-R1, IL-6, and the development of fatigue in patients with gastrointestinal cancer undergoing chemoradiation therapy Brain Behav Immun 26 2012 699 705
29. M. Inagaki, M. Isono, T. Okuyama, Y. Sugawara, T. Akechi, and N. Akizuki Plasma interleukin-6 and fatigue in terminally ill cancer patients J Pain Symptom Manage 35 2008 153 161
30. B.J. Laird, D.C. McMillan, P. Fayers, K. Fearon, S. Kaasa, and M.T. Fallon The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer Oncologist 18 2013 1050 1055
31. M.R. Irwin, and A.H. Miller Depressive disorders and immunity: 20 years of progress and discovery Brain Behav Immun 21 2007 374 383
32. J.P. Monk, G. Phillips, R. Waite, J. Kuhn, L.J. Schaaf, and G.A. Otterson Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients J Clin Oncol 24 2006 1852 1859
33. J.E. Bower, G. Greendale, A.D. Crosswell, D. Garet, B. Sternlieb, and P.A. Ganz Yoga reduces inflammatory signaling in fatigued breast cancer survivors: a randomized controlled trial Psychoneuroendocrinology 43 2014 20 29
34. J.K. Payne Altered circadian rhythms and cancer-related fatigue outcomes Integr Cancer Ther 10 2011 221 233
35. T.M. Atkinson, Y. Li, C.W. Coffey, L. Sit, M. Shaw, and D. Lavene Reliability of adverse symptom event reporting by clinicians Qual Life Res 21 2012 1159 1164
36. US Food and Drug Administration Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims Silver Spring MD: US Department of Health and Human Services 2009 Available from: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM071975.pdf Last updated: Dec, 2009. Accessed: Jul 31, 2014.
37. E. Basch, X. Jia, G. Heller, A. Barz, L. Sit, and M. Fruscione Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes J Natl Cancer Inst 101 2009 1624 1632
38. K. Olson A new way of thinking about fatigue: a reconceptualization Oncol Nurs Forum 34 2007 93 99
39. C.S. Cleeland, and X.S. Wang Measuring and understanding fatigue Oncology 13 1999 91 97
40. N.H. Hjollund, J.H. Andersen, and P. Bech Assessment of fatigue in chronic disease: a bibliographic study of fatigue measurement scales Health Qual Life Outcomes 5 2007 12 16
41. X.S. Wang, C.S. Cleeland, T.R. Mendoza, Y.H. Yun, Y. Wang, and T. Okuyama Impact of cultural and linguistic factors on symptom reporting by patients with cancer J Natl Cancer Inst 102 2010 732 738
42. J.S. Lai, P.K. Crane, and D. Cella Factor analysis techniques for assessing sufficient unidimensionality of cancer related fatigue Qual Life Res 15 2006 1179 1190
43. L.B. Krupp, N.G. LaRocca, J. Muir-Nash, and A.D. Steinberg The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus Arch Neurol 46 1989 1121 1123
44. N.K. Aaronson, S. Ahmedzai, B. Bergman, M. Bullinger, A. Cull, and N.J. Duez The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
45. E.M.A. Smets, B. Garssen, B. Bonke, and J.C.J.M. De Haes The Multidimensional Fatigue Inventory (MFI): psychometric qualities of an instrument to assess fatigue J Psychosom Res 39 1995 315 325
46. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: cancer-related fatigue Available from http://www.nccn.org/professionals/physician-gls/PDF/fatigue.pdf [Last updated: Aug 28, 2007. Accessed: Sep 13, 2007]
47. R.T. Ho, T.C. Fong, and I.K. Cheung Cancer-related fatigue in breast cancer patients: factor mixture models with continuous non-normal distributions Qual Life Res 2014 [Epub 2014 Jun 5]
48. R.C. Serlin, T.R. Mendoza, Y. Nakamura, K.R. Edwards, and C.S. Cleeland When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function Pain 61 1995 277 284
49. C.S. Cleeland, R. Gonin, A.K. Hatfield, J.H. Edmonson, R.H. Blum, and J.A. Stewart Pain and its treatment in outpatients with metastatic cancer N Engl J Med 330 1994 592 596
50. M.J. Fisch, F. Zhao, A.M. O'Mara, X.S. Wang, D. Cella, and C.S. Cleeland Predictors of significant worsening of patient-reported fatigue over a 1-month timeframe in ambulatory patients with common solid tumors Cancer 120 2014 442 450
51. C.S. Denlinger, J.A. Ligibel, M. Are, K.S. Baker, W. Demark-Wahnefried, and D.L. Friedman Survivorship: fatigue, version 1.2014 J Natl Compr Canc Netw 12 2014 876 887
52. National Comprehensive Cancer Network NCCN Clinical Practice Guidelines in Oncology: cancer- and chemotherapy-induced anemia Available from http://www.nccn.org/professionals/physician-gls/PDF/anemia.pdf [Last updated: 2012. Accessed: Feb 16, 2012]
53. M. De La Cruz, D. Hui, H.A. Parsons, and E. Bruera Placebo and nocebo effects in randomized double-blind clinical trials of agents for the therapy for fatigue in patients with advanced cancer Cancer 116 2010 766 774
54. O. Minton, A. Richardson, M. Sharpe, M. Hotopf, and P.C. Stone Psychostimulants for the management of cancer-related fatigue: a systematic review and meta-analysis J Pain Symptom Manage 41 2011 761 767
55. S. Gong, P. Sheng, H. Jin, H. He, E. Qi, and W. Chen Effect of methylphenidate in patients with cancer-related fatigue: a systematic review and meta-analysis PLoS One 9 2014 e84391
56. O. Paulsen, P. Klepstad, J.H. Rosland, N. Aass, E. Albert, and P. Fayers Efficacy of methylprednisolone on pain, fatigue, and appetite loss in patients with advanced cancer using opioids: a randomized, placebo-controlled, double-blind trial J Clin Oncol 10;32 29 2014 3221 3228 [Epub 2014 Jul 7]
57. P. Jean-Pierre, G.R. Morrow, J.A. Roscoe, C. Heckler, S. Mohile, and M. Janelsins A phase 3 randomized, placebo-controlled, double-blind, clinical trial of the effect of modafinil on cancer-related fatigue among 631 patients receiving chemotherapy: a University of Rochester Cancer Center Community Clinical Oncology Program Research base study Cancer 116 2010 3513 3520
58. A. Spathis, K. Fife, F. Blackhall, S. Dutton, R. Bahadori, and R. Wharton Modafinil for the treatment of fatigue in lung cancer: results of a placebo-controlled, double-blind, randomized trial J Clin Oncol 32 2014 1882 1888
59. G.R. Morrow, J.T. Hickok, J.A. Roscoe, R.F. Raubertas, P.L. Andrews, and P.J. Flynn Differential effects of paroxetine on fatigue and depression: a randomized, double-blind trial from the University of Rochester Cancer Center Community Clinical Oncology Program J Clin Oncol 21 2003 4635 4641
60. J.A. Roscoe, G.R. Morrow, J.T. Hickok, K.M. Mustian, J.J. Griggs, and S.E. Matteson Effect of paroxetine hydrochloride (Paxil) on fatigue and depression in breast cancer patients receiving chemotherapy Breast Cancer Res Treat 89 2005 243 249
61. E.L. Moss, J.S. Simpson, G. Pelletier, and P. Forsyth An open-label study of the effects of bupropion SR on fatigue, depression and quality of life of mixed-site cancer patients and their partners Psychooncology 15 2006 259 267
62. D.L. Barton, H. Liu, S.R. Dakhil, B. Linquist, J.A. Sloan, and C.R. Nichols Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2 J Natl Cancer Inst 105 2013 1230 1238
63. C.X. Su, L.Q. Wang, S.J. Grant, and J.P. Liu Chinese herbal medicine for cancer-related fatigue: a systematic review of randomized clinical trials Complement Ther Med 22 2014 567 579
64. K.L. Kwekkeboom, C.H. Cherwin, J.W. Lee, and B. Wanta Mind-body treatments for the pain-fatigue-sleep disturbance symptom cluster in persons with cancer J Pain Symptom Manage 39 2010 126 138
65. M. Kangas, D.H. Bovbjerg, and G.H. Montgomery Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients Psychol Bull 134 2008 700 741
66. P.B. Jacobsen, K.A. Donovan, S.T. Vadaparampil, and B.J. Small Systematic review and meta-analysis of psychological and activity-based interventions for cancer-related fatigue Health Psychol 26 2007 660 667
67. K.H. Schmitz, J. Holtzman, K.S. Courneya, L.C. Mâsse, S. Duval, and R. Kane Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis Cancer Epidemiol Biomarkers Prev 14 2005 1588 1595
68. M. Markes, T. Brockow, and K.L. Resch Exercise for women receiving adjuvant therapy for breast cancer Cochrane Database Syst Rev 2006 CD005001
69. K.M. Mustian, G.R. Morrow, J.K. Carroll, C.D. Figueroa-Moseley, P. Jean-Pierre, and G.C. Williams Integrative nonpharmacologic behavioral interventions for the management of cancer-related fatigue Oncologist 12 2007 52 67
70. S.M. George, C.M. Alfano, M.L. Neuhouser, A.W. Smith, R.N. Baumgartner, and K.B. Baumgartner Better postdiagnosis diet quality is associated with less cancer-related fatigue in breast cancer survivors J Cancer Surviv 2014 [Epub 2014 Jul 8]